# Trandolapril and Verapamil Hydrochloride

NDC: 68462-329
Generic name: Trandolapril and Verapamil Hydrochloride
Labeler / Manufacturer: Glenmark Pharmaceuticals Inc., USA
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20150225

FDA application: ANDA079135

## Active ingredients

- TRANDOLAPRIL: 4 mg/1
- VERAPAMIL HYDROCHLORIDE: 240 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68462-329"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68462-329
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=39bad727-af4c-4d20-933b-7f287e88099a
